U
Ustekinumab
Availability of ACE Drug Guidance
Yes
Biologics Drug Information Overview
Yes
Subsidy Information and Financing Scheme
No
Active ingredient: Ustekinumab
General information
Subsidy Information and Financing Scheme
Not Applicable
Drug Guidance for Subsidy
06/02/2026 Ustekinumab biosimilar for treating inflammatory conditions
The Ministry of Health’s Drug Advisory Committee has recommended ustekinumab biosimilar (Steqeyma) 45 mg/0.5 mL pre-filled syringe, 90 mg/1 mL pre-filled syringe, and 130 mg/26 mL vial for listing on the MOH Standard Drug List (SDL). The decision was based on the acceptable pricing proposal from the company.
Funding status
[R] SDL subsidy will apply from 1 April 2026 to all registered indications of ustekinumab biosimilar (Steqeyma) 45 mg/0.5 mL pre-filled syringe, 90 mg/1 mL pre-filled syringe, and 130 mg/26 mL vial in Singapore.
[NR] SDL subsidy does not apply to other brand(s), formulation(s) or strength(s) of ustekinumab.
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Stelara Injection, Solution 45 mg/0.5 mL |
|
Stelara Injection, Solution (Pre-Filled Syringe) 90 mg/1 mL |
|
Stelara Infusion, Solution Concentrate 130 mg/vial |
|
Stelara Injection, Solution (Pre-Filled Pen) 90 mg/1 mL |
|
Steqeyma® Injection, Solution 45 mg/0.5 mL |
|
Steqeyma® Injection, Solution 90 mg/mL |
|
Steqeyma® Infusion, Solution Concentrate 130 mg/26 mL |
|